Skip to content

Genetic Modifiers of Cystic Fibrosis Related Diabetes

Genetic Modifiers of Cystic Fibrosis Related Diabetes

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01113216
Enrollment
1500
Registered
2010-04-29
Start date
2008-04-01
Completion date
2030-04-01
Last updated
2026-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Fibrosis Related Diabetes

Keywords

CF, CFRD, Diabetes, Genetic Modifiers

Brief summary

This research is being done to find the genes and other factors that are responsible for differences among persons with cystic fibrosis. We are particularly interested in the factors that relate to the development of Cystic Fibrosis Related Diabetes (CFRD).

Detailed description

The study is recruiting people with cystic fibrosis (CF). The medical record is being extracted, and a blood sample is taken for DNA. The DNA samples are tested for variation both at the cystic fibrosis transmembrane conductance regulator (CFTR) gene (the CF gene) and over the entire rest of the genome. Using large numbers of people with CF, and knowing who does and does not have CFRD, we identify genetic variations that associate with CFRD. Knowing these variations allows us to better understand the causes of CFRD, and with enough information, better to predict CFRD and identify people at particularly high or low risk of CFRD. People participating in this study also have the option to participate in related studies of other metabolic traits in CF such as over- and underweight.

Interventions

None listed

Sponsors

Johns Hopkins University
Lead SponsorOTHER
Cystic Fibrosis Foundation
CollaboratorOTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
University of Minnesota
CollaboratorOTHER
Northwestern University
CollaboratorOTHER

Study design

Observational model
FAMILY_BASED
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Months to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* Any person with Cystic Fibrosis and his/her parents.

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Identification of Genes or other factors that influence the development of CFRD5 years

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORScott M Blackman, MD, PhD

Johns Hopkins University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 14, 2026